This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of testis
C3_TESTIS
testicular carcinoma: A primary or metastatic malignant neoplasm that affects the testis. Representative examples include seminoma, embryonal carcinoma, sarcoma, leukemia, and lymphoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditionsNone |
244368 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
698 |
4. Check minimum number of eventsNone |
698 |
5. Include endpointsNone |
698 |
6. Filter based on genotype QC (FinnGen only) |
620 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of testis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of testis, including Hilmo
- malignant neoplasm of male genital organs
- malignant neoplasm of male genital organs, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 620 | - | 620 |
| Unadjusted period prevalence (%) | 0.28 | - | 0.28 |
| Median age at first event (years) | 36.03 | - | 36.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 656
- Matched controls
- 6560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
681.8
307.7
400
15
KFC00
NOMESCO Finland
Unilateral orchiectomy
1033.6
307.7
478
17
JN4BD
NOMESCO Finland
Extensive body CT
33.4
307.7
253
121
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
303.4
267
*
A03FA01
ATC
metoclopramide; systemic, rectal
18.0
271.4
266
239
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
259.1
231
*
130
Kela drug reimbursment
Malignant tumour
+∞
244.5
219
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
17.7
212.0
195
153
JN4AD
NOMESCO Finland
Body CT examination
17.2
204.9
191
153
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
186.6
170
*
H02AB02
ATC
dexamethasone; systemic
50.9
182.6
107
25
A04AA01
ATC
ondansetron; systemic, rectal
32.6
161.2
107
39
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
138.6
128
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
110.6
103
*
A04AA02
ATC
granisetron; systemic, transdermal
1148.0
103.1
98
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
100.7
94
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
177.9
89.7
92
6
121
Kela drug reimbursment
Severe hypofunction of sexual glands
30.8
88.6
59
21
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
85.3
80
*
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
85.3
80
*
L03AA02
ATC
filgrastim; parenteral
187.0
80.1
82
5
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
78.8
74
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
75.5
71
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
67.8
403
1848
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
65.7
62
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
62.5
59
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
167.8
59.0
61
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.7
58.1
302
1236
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
57.1
54
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.9
56.9
115
229
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
56.0
53
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
584.9
55.4
54
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
53.6
147
380
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
51.8
49
*
L03AA13
ATC
pegfilgrastim; parenteral
537.7
51.2
50
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.8
50.1
73
103
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
47.5
45
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
47.5
45
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
491.1
46.9
46
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
44.3
42
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
44.3
42
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
433.7
41.6
41
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
41.1
39
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
422.3
40.6
40
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
40.0
38
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
40.0
38
*
N02AA05
ATC
oxycodone; systemic
4.3
39.8
117
315
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
38.9
37
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
37.9
36
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.2
37.2
114
316
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
37.0
204
827
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
36.8
35
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
36.8
35
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
51.0
36.1
43
9
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
35.8
34
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
35.4
121
362
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
33.6
32
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
33.6
32
*
ZXE00
NOMESCO Finland
One hour or less
2.7
32.8
264
1300
Z51.5
ICD-10 Finland
Palliative care
7.6
32.2
47
66
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.7
31.7
46
64
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
31.5
30
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
327.8
31.1
31
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
167.9
31.0
32
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
30.4
29
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
30.4
29
*
WW500
NOMESCO Finland
Blood transfusion
10.2
29.7
34
35
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
29.4
28
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
29.4
28
*
Y05
ICPC
Scrotum/testis sympt/compl other
7.5
28.7
42
59
E29.1
ICD-10 Finland
Testicular hypofunction
6.0
28.3
52
93
WX402
NOMESCO Finland
General anaesthesia
2.8
26.9
166
703
WX320
NOMESCO Finland
Spinalanesthesy
2.8
25.6
156
654
B01AB10
ATC
tinzaparin; parenteral
4.3
25.4
69
173
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
25.2
24
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.9
25.0
57
124
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
24.1
23
*
Y78
ICPC
Malign neopl male genital other
+∞
24.1
23
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
23.3
223
1156
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
23.1
45
85
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
23.1
22
*
L01BC06
ATC
capecitabine; oral
+∞
23.1
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
238.0
22.8
23
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
22.5
87
279
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.6
22.0
36
57
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
22.0
21
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
22.0
21
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
22.0
21
*
DFF00
NOMESCO Finland
Pure tone audiometry
3.4
21.5
83
266
JN4CD
NOMESCO Finland
Very extensive body CT
17.6
20.7
32
19
XW000
NOMESCO Finland
Bone marrow biopsy
8.1
20.6
28
36
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
8.7
20.3
26
31
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
19.9
19
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
19.4
57
151
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
19.4
216
1179
B01AB05
ATC
enoxaparin; parenteral
2.4
19.2
156
744
116
Kela drug reimbursment
Prostate cancer
+∞
18.8
18
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
18.8
18
*
WZC30
NOMESCO Finland
Teaching
2.8
18.8
108
434
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.8
18.7
107
429
D29.2
ICD-10 Finland
Benign neoplasm: Testis
39.7
18.7
23
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.7
18.4
26
35
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
17.8
17
*
A04AD12
ATC
aprepitant; systemic
+∞
17.8
17
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
17.8
17
*
ZX120
NOMESCO Finland
Intravenous
3.6
17.7
62
186
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
16.7
16
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.7
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.7
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.5
16.6
24
33
KF8AE, ,
SPAT
4.9
16.5
37
79
N02BE01
ATC
paracetamol; systemic, rectal
2.5
16.2
556
4530
N46
ICD-10 Finland
Male infertility
4.2
15.9
43
107
N50.9
ICD-10 Finland
Disorder of male genital organs, unspecified
7.4
15.8
23
32
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
15.7
15
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
15.7
15
*
JN6AD
NOMESCO Finland
CT of torso and neck
22.7
15.6
22
10
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.4
15.6
26
42
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
82.0
14.6
16
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
54.6
13.9
16
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
13.6
13
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
142.8
13.5
14
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
13.4
105
487
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
12.5
12
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
12.5
12
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
12.5
12
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.5
12
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
12.5
12
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
12.3
66
255
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
12.2
26
53
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
12.2
64
244
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
12.1
110
543
R50.9
ICD-10 Finland
Fever, unspecified
2.2
11.9
111
554
ZX090
NOMESCO Finland
Other technic of radiotherapy
66.2
11.6
13
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
11
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.5
11
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
11.5
11
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
11.5
11
*
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
11.3
42
131
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
11.2
135
742
B01AB04
ATC
dalteparin; parenteral
4.4
10.9
27
63
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
10.8
115
602
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.5
10.8
26
59
WX702
NOMESCO Finland
Supraglottic ventilation device
3.2
10.7
43
141
7513
FHL
Test prosthesis installation
61.0
10.7
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
10.4
10
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
33.1
10.4
13
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.7
10.3
33
93
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
4.6
10.1
24
54
KFA00
NOMESCO Finland
Exploration of testis
8.9
9.8
20
23
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
9.8
42
143
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
9.8
28
73
M04AA01
ATC
allopurinol; systemic
2.2
9.7
82
392
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
9.4
32
94
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
9.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
9.4
9
*
ZXA05
NOMESCO Finland
Left side
1.9
9.4
128
731
A02BC02
ATC
pantoprazole; systemic
1.7
9.1
373
2901
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.2
9.1
18
20
J01MA12
ATC
levofloxacin; systemic
2.1
9.1
96
501
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
37.2
9.0
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.7
239
1674
R4190
NOMESCO Finland
Nutritional therapy
3.9
8.6
25
66
KA1FN
NOMESCO Finland
Isotope renography
16.6
8.6
13
8
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
91.2
8.4
9
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
8.3
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
8.3
8
*
Y77
ICPC
Malignant neoplasm prostate
+∞
8.3
8
*
L02BB03
ATC
bicalutamide; oral
+∞
8.3
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.3
8
*
Y28
ICPC
Limited function/disability (Y)
9.6
8.3
16
17
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
8.3
38
135
R4110
NOMESCO Finland
Physiotherapy
1.8
8.2
145
896
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
8.1
60
270
KFB00
NOMESCO Finland
Biopsy of testis
17.4
8.1
12
7
ZXA00
NOMESCO Finland
Right side
1.8
8.0
132
798
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
13.2
7.9
13
10
Z31.8
ICD-10 Finland
Other procreative management
45.5
7.7
9
*
ZXD05
NOMESCO Finland
Urgent procedure
1.7
7.4
165
1085
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
11.0
7.3
13
12
C03CA01
ATC
furosemide; systemic
1.8
7.3
125
763
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
7.2
46
194
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.1
7.0
16
23
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
40.5
6.8
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.7
93
532
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.5
6.7
16
25
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
6.7
50
227
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
6.6
39
159
A02BX02
ATC
sucralfate; oral
4.0
6.5
18
46
JAH01
NOMESCO Finland
Laparoscopy
4.1
6.4
17
42
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
9680/3-C62.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of descended testis
+∞
6.3
6
*
1869C
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),MUU TAI TARK MÄÄRITT]
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
1860A
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOPL MAL TESTIS (ABDOMIN/INGUIN),SEMINOMA]
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.4
6.2
17
32
A41.9
ICD-10 Finland
Sepsis, unspecified
3.1
6.1
25
83
WX892
NOMESCO Finland
Monitored bed care
2.2
6.1
49
229
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
186
12
215.94
307.65
11.0
1.2
509.42
—
pmol/l
—
124
0
163
105
20.33
195.87
3.6
1.4
16.25
7.46
iu/l
5.37
124
80
211
251
11.92
174.07
3.3
1.5
7.79
4.00
u/l
6.82
171
207
325
1084
4.96
90.80
4.7
2.5
13.26
15.50
nmol/l
6.98
314
1014
480
2317
4.99
79.19
10.7
4.8
11.07
12.96
umol/l
3.60
475
2222
563
3624
4.90
50.72
13.8
6.5
76.75
75.77
u/l
0.27
557
3457
471
2720
3.59
49.32
13.4
9.0
3.70
4.19
e9/l
4.17
421
2369
276
1235
3.13
43.21
5.7
2.2
2.36
2.35
mmol/l
0.63
256
1116
49
9
58.66
42.07
8.7
2.1
3.63
3.67
ug/l
—
49
9
181
662
3.39
39.29
5.8
2.0
2.44
2.42
mmol/l
1.70
164
584
342
1882
2.71
34.34
9.6
4.8
36.51
37.04
g/l
0.89
321
1758
327
1763
2.70
34.17
3.1
2.6
—
—
estimate
—
0
0
243
1191
2.65
29.92
3.4
2.9
0.50
0.28
e6/l
0.45
182
853
356
2101
2.52
29.47
10.6
7.4
1.20
1.20
mmol/l
0.40
291
1836
72
167
4.72
29.33
5.8
2.2
4.29
2.54
ug/l
1.96
57
134
268
1389
2.57
29.27
3.7
3.0
56.59
115.58
e6/l
0.43
205
1047
322
1846
2.46
27.96
9.3
7.2
1.21
1.20
mmol/l
0.39
315
1709
49
88
5.94
26.54
1.6
3.4
41.78
45.94
%
0.62
49
88
49
88
5.94
26.54
3.3
6.7
10.14
8.50
%
0.95
49
88
420
2757
2.45
26.37
6.4
5.6
6.64
6.79
mmol/l
0.67
406
2649
355
2183
2.36
25.59
12.8
10.2
0.00
0.00
e9/l
0.46
286
1799
219
1136
2.39
22.79
5.4
4.3
91.58
87.31
%
2.05
214
1119
155
686
2.65
22.64
3.3
2.7
0.39
0.55
e6/l
0.39
86
321
161
737
2.57
21.88
3.1
2.7
0.90
0.87
e6/l
0.03
95
373
322
2023
2.16
20.55
15.7
14.8
1.23
1.26
inr
0.64
274
1700
228
1255
2.25
20.23
3.6
2.5
363.31
376.82
umol/l
1.41
215
1139
177
928
2.24
17.28
2.9
2.4
—
—
—
0
0
187
1006
2.20
17.11
1.8
1.9
1.19
0.99
mg/l
0.62
139
724
175
936
2.19
16.13
3.0
2.5
2.89
2.24
e6/l
0.55
158
854
20
6
34.31
15.81
1.2
1.0
—
—
—
0
0
597
5113
2.86
14.21
25.5
14.8
139.48
139.80
mmol/l
3.44
589
5008
585
4970
2.64
13.98
23.6
11.3
90.06
89.86
ml/min/173m2
0.07
548
4541
597
5134
2.81
13.69
25.9
14.8
3.99
4.00
mmol/l
0.67
587
5020
130
668
2.18
12.99
9.7
9.3
104.58
104.34
mmol/l
0.28
130
668
137
727
2.12
12.57
2.6
1.8
—
—
—
0
0
31
73
4.41
12.32
1.9
1.8
—
—
—
0
0
38
105
3.78
12.22
2.0
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
121
3.55
11.98
3.8
3.2
0.32
0.33
iu/ml
0.11
22
59
593
5167
2.54
11.67
23.0
12.3
23.57
25.02
mg/l
0.52
515
4082
36
108
3.47
10.27
2.0
1.6
—
—
—
0
0
127
716
1.96
9.69
3.3
2.6
12.86
14.61
umol/l
1.96
118
665
38
124
3.19
9.51
7.2
6.3
656.22
560.12
iu/ml
—
9
16
87
434
2.16
9.23
4.1
3.1
—
—
—
0
0
111
619
1.95
8.69
3.5
2.6
24.18
25.80
%
0.68
103
578
27
76
3.66
8.48
1.3
1.5
—
—
—
0
0
64
297
2.28
8.08
2.1
1.7
—
—
—
0
0
101
568
1.92
7.68
2.6
1.7
—
—
—
0
0
58
264
2.31
7.66
10.7
16.6
16.42
16.60
%
0.16
58
255
115
675
1.85
7.66
3.4
2.6
2.26
2.27
g/l
0.05
106
627
28
87
3.32
7.60
2.4
3.1
—
481.63
—
0
8
307
2356
1.57
7.34
3.3
3.1
0.01
8.11
estimate
0.80
80
451
17
38
4.57
7.21
2.1
1.7
—
—
—
0
0
96
542
1.90
7.20
2.6
1.8
—
—
—
0
0
302
2332
1.55
6.88
3.4
3.1
0.00
0.00
estimate
-0.00
81
455
509
4446
1.65
6.52
30.0
15.0
13.52
13.28
%
4.12
503
4386
304
2370
1.53
6.52
3.4
3.1
0.00
0.02
estimate
0.79
73
402
17
43
4.03
6.20
1.2
1.2
—
—
—
0
0
51
244
2.18
6.01
1.8
1.4
—
—
—
0
0
20
59
3.46
5.90
1.6
1.6
—
—
—
0
0
88
517
1.81
5.80
5.4
2.4
13.44
8.83
umol/l
0.58
78
460
66
361
1.92
5.44
2.3
2.3
63.13
70.45
ml/min/173m2
0.43
23
144
8
5
16.18
5.42
1.0
1.0
—
—
—
0
0
189
1376
1.52
5.36
3.2
2.5
0.00
0.00
estimate
-0.00
63
350
10
11
9.21
5.30
2.3
1.4
—
—
—
0
0
10
11
9.21
5.30
2.3
1.4
—
—
—
0
0
10
11
9.21
5.30
2.3
1.4
—
—
—
0
0
52
265
2.05
5.23
2.2
1.5
—
—
—
0
0
343
2821
1.45
5.22
4.7
3.5
2.32
1.58
ug/l
0.58
306
2580
16
35
4.66
5.20
2.2
1.7
—
—
—
0
0
77
452
1.80
5.09
3.8
2.6
29.71
140.84
u/l
0.54
62
390
21
71
3.02
5.03
1.5
1.4
—
—
—
0
0
199
1482
1.49
5.02
3.4
2.7
54.40
62.02
u/l
1.34
183
1400
19
62
3.13
4.82
1.7
1.9
—
—
—
0
0
23
84
2.80
4.82
1.5
1.4
—
—
—
0
0
29
120
2.48
4.78
1.4
1.6
—
—
—
0
0
25
98
2.61
4.60
1.6
1.4
243.57
304.49
ug/g
0.54
14
56
29
124
2.40
4.47
1.3
1.3
155.00
144.13
au/ml
0.30
12
39
23
88
2.67
4.44
1.5
1.8
—
—
—
0
0
10
16
6.33
4.30
2.3
1.4
—
—
—
0
0
10
16
6.33
4.30
2.3
1.4
—
—
—
0
0
10
16
6.33
4.30
2.3
1.4
—
—
—
0
0
10
16
6.33
4.30
2.3
1.4
—
—
—
0
0
86
548
1.66
4.25
10.5
11.4
0.76
1.11
mmol/l
0.48
74
452
14
41
3.47
4.20
2.6
2.5
0.53
0.80
e9/l
1.59
14
41
404
3500
1.40
4.19
4.3
3.9
11.59
8.30
mm/h
3.74
379
3300
25
105
2.44
4.02
1.5
1.5
—
—
—
0
0
81
517
1.65
3.98
5.5
3.7
1.41
1.72
mmol/l
0.42
72
441
231
1845
1.39
3.80
3.3
3.0
0.00
0.00
estimate
-0.00
73
384
81
532
1.60
3.56
5.5
3.7
5.85
5.92
kpa
0.27
81
514
164
1248
1.42
3.54
3.5
3.4
1088.46
1370.56
ng/l
0.60
139
1034
30
145
2.12
3.53
3.0
1.7
—
—
—
0
0
50
290
1.78
3.49
1.5
1.5
—
—
—
0
0
21
88
2.43
3.42
1.3
1.5
—
—
—
0
0
71
456
1.62
3.42
12.1
13.0
120.99
128.17
g/l
1.90
71
444
137
1015
1.44
3.42
2.5
2.2
2.93
2.74
mg/l
0.41
118
868
24
108
2.27
3.36
3.3
2.4
130.81
137.52
g/l
0.45
16
83
12
33
3.68
3.30
2.3
1.3
—
—
—
0
0
12
33
3.68
3.30
2.3
1.3
—
—
—
0
0
12
33
3.68
3.30
2.3
1.3
—
—
—
0
0
6
7
8.64
3.27
2.7
1.1
11.00
11.79
u/l
—
6
7
620
5926
1.84
3.24
36.2
18.2
233.52
238.75
e9/l
1.53
606
5815
15
55
2.77
3.17
1.5
1.7
244.40
268.00
mu/l
0.22
15
45
68
442
1.60
3.14
2.3
1.8
368.95
363.05
nmol/l
0.10
62
411
620
5934
1.82
3.11
36.1
18.1
4.67
4.82
e12/l
9.04
604
5817
10
25
4.05
3.09
1.4
2.4
—
—
—
0
0
36
196
1.89
3.08
2.4
3.2
4.82
4.79
pmol/l
0.03
31
178
15
58
2.62
2.89
1.1
1.2
—
—
—
0
0
48
292
1.69
2.87
4.1
3.2
0.84
1.85
mmol/l
1.28
35
208
19
83
2.33
2.86
1.4
1.3
—
—
—
0
0
19
83
2.33
2.86
1.4
1.3
—
—
—
0
0
26
130
2.04
2.84
2.4
1.6
—
—
—
0
0
221
1821
1.32
2.82
4.8
3.2
36.23
37.22
u/l
0.10
213
1723
10
28
3.61
2.79
1.4
1.5
—
—
—
0
0
9
24
3.79
2.68
1.7
2.3
—
—
—
0
0
9
24
3.79
2.68
1.4
1.6
—
—
—
0
0
38
222
1.76
2.63
4.4
3.1
23.86
25.03
mmol/l
1.49
38
211
199
1630
1.32
2.62
2.8
2.5
0.69
0.69
ug/l
0.02
124
853
17
75
2.30
2.53
2.2
1.4
4.33
8.19
u/ml
—
6
27
9
26
3.49
2.49
1.4
1.6
—
—
—
0
0
11
38
2.93
2.42
3.5
2.7
—
—
—
0
0
6
12
5.03
2.40
2.0
1.8
1.01
1.91
ratio
—
6
12
54
359
1.55
2.31
3.5
2.2
0.46
0.26
e6/l
0.27
54
342
22
113
1.98
2.28
1.1
1.3
—
—
—
0
0
6
13
4.65
2.27
1.5
4.0
—
—
—
0
0
151
1212
1.32
2.27
3.4
3.3
0.03
0.01
estimate
0.27
72
408
5
9
5.59
2.21
1.2
1.1
—
—
—
0
0
36
219
1.68
2.20
6.5
6.5
1.69
1.65
%
0.08
36
205
15
67
2.27
2.19
1.2
1.1
—
—
—
0
0
9
30
3.03
2.15
1.4
1.2
—
—
—
0
0
9
30
3.03
2.15
1.3
1.2
—
—
—
0
0
11
42
2.65
2.15
1.4
1.1
—
—
—
0
0
10
36
2.80
2.14
1.4
1.2
—
—
—
0
0
89
666
1.39
2.10
2.0
1.8
1059.20
1161.30
nmol/l
0.58
64
528
16
75
2.16
2.10
2.3
1.3
6.33
4.24
u/ml
—
9
42
42
270
1.59
2.09
7.0
4.6
121.15
101.04
ng/l
0.63
34
240
9
31
2.93
2.08
1.4
1.2
—
—
—
0
0
9
31
2.93
2.08
1.4
1.2
—
—
—
0
0
10
37
2.73
2.07
1.5
1.5
—
—
—
0
0
69
496
1.44
2.05
4.2
4.4
29.38
29.04
%
0.08
52
356
28
164
1.74
1.98
1.2
1.2
249.15
257.71
u/ml
0.06
20
96
5
11
4.57
1.94
8.4
1.9
1.60
1.41
%
—
5
11
6
16
3.77
1.94
1.0
1.3
—
—
—
0
0
9
33
2.75
1.93
1.4
1.2
—
—
—
0
0
16
78
2.08
1.92
4.6
4.1
12.75
11.38
pmol/l
0.11
16
78
220
1889
1.25
1.91
4.1
3.5
45.89
51.45
ng/l
0.12
164
1246
223
1921
1.24
1.87
2.0
1.9
94.28
95.60
pmol/l
0.17
133
1103
11
46
2.42
1.86
1.7
2.0
—
—
—
0
0
5
12
4.19
1.82
2.0
2.3
0.62
0.62
mmol/l
—
5
12
22
124
1.80
1.78
1.5
1.2
—
—
—
0
0
18
95
1.92
1.77
2.4
1.2
1.54
1.40
ratio
—
10
48
62
454
1.40
1.69
5.0
3.1
5.07
4.60
kpa
0.89
62
436
26
158
1.67
1.64
2.0
3.7
—
—
—
0
0
6
21
2.87
1.51
1.3
1.1
—
—
—
0
0
374
3452
1.19
1.45
3.4
3.0
14.91
14.86
pmol/l
0.14
339
3172
20
118
1.72
1.42
1.3
1.4
128.06
191.90
pmol/l
1.13
20
118
15
82
1.85
1.36
1.1
1.1
—
—
—
0
0
5
17
2.96
1.36
1.2
2.2
—
—
—
0
0
5
17
2.96
1.36
1.2
2.2
—
—
—
0
0
135
1141
1.23
1.33
1.6
1.6
18.20
18.60
nmol/l
0.13
117
1001
21
129
1.65
1.31
1.1
1.2
852.81
517.85
mg/l
0.67
21
121
9
43
2.11
1.30
1.0
1.2
—
—
—
0
0
16
91
1.78
1.30
4.5
3.0
7.00
7.15
mmol/l
0.10
16
86
9
44
2.06
1.27
3.6
3.9
—
—
—
0
0
18
107
1.70
1.27
1.2
1.2
3.51
3.85
mmol/l
0.61
18
99
19
115
1.67
1.26
4.1
2.8
1.35
1.55
mmol/l
0.99
19
107
8
36
2.24
1.24
15.8
4.2
0.50
1.03
index
—
8
36
10
49
2.06
1.22
1.9
1.2
—
—
—
0
0
521
5406
0.82
1.19
5.1
5.1
2.79
2.80
mmol/l
0.11
493
5153
27
182
1.50
1.17
1.4
1.7
—
—
—
0
0
10
50
2.02
1.17
1.9
1.2
—
—
—
0
0
10
50
2.02
1.17
1.9
1.2
—
—
—
0
0
27
183
1.50
1.15
2.4
2.6
222.30
701.08
ug/l
1.25
27
178
16
96
1.68
1.11
1.1
1.6
—
—
—
0
0
7
31
2.27
1.10
1.0
1.1
—
—
—
0
0
12
66
1.83
1.09
1.8
2.2
19.83
21.96
nmol/l
0.35
12
59
7
33
2.13
1.06
1.9
2.6
—
—
—
0
0
15
90
1.68
1.04
1.5
1.1
—
—
—
0
0
48
369
1.32
1.03
1.1
1.4
—
—
—
0
0
9
47
1.93
1.02
2.0
1.2
—
—
—
0
0
9
47
1.93
1.02
2.0
1.2
—
—
—
0
0
9
47
1.93
1.02
2.0
1.2
—
—
—
0
0
21
309
0.67
1.02
1.3
1.6
—
—
—
0
0
36
266
1.37
1.00
5.6
3.4
51.01
50.70
%
0.02
36
257
5
23
2.18
0.98
1.0
1.8
—
—
—
0
0
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
516
5334
0.85
0.96
4.7
4.6
1.25
1.28
mmol/l
1.11
485
5080
488
5065
0.86
0.95
4.0
4.0
1.47
1.40
mmol/l
1.09
454
4802
104
888
1.20
0.95
2.0
2.3
—
—
—
0
0
7
37
1.90
0.94
1.3
1.1
—
—
—
0
0
243
2224
1.15
0.94
3.7
3.3
22.98
23.82
%
0.30
99
807
519
5358
0.85
0.92
4.7
4.6
4.59
4.58
mmol/l
0.09
490
5132
12
71
1.70
0.89
1.3
2.2
4.30
5.43
mmol/24h
0.79
12
63
6
30
2.01
0.87
1.8
2.2
—
—
—
0
0
109
948
1.18
0.82
4.1
3.7
457.86
799.86
ng/l
0.77
86
695
16
105
1.54
0.82
1.1
1.3
—
562.86
—
0
7
25
339
0.73
0.81
2.6
2.5
31.32
13.94
au/ml
—
5
49
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
459
4416
1.13
0.74
4.2
3.8
1.82
1.86
mu/l
0.34
419
4093
9
55
1.65
0.73
1.1
1.1
—
—
—
0
0
109
958
1.17
0.73
2.0
2.3
—
—
—
0
0
5
25
2.01
0.73
3.2
1.1
—
—
—
0
0
219
2022
1.12
0.72
3.8
2.7
181.56
163.09
ug/l
0.64
200
1899
21
152
1.39
0.70
1.8
2.7
14.36
10.51
mg/l
0.99
21
143
475
4904
0.89
0.69
6.1
5.6
38.86
38.91
mmol/mol
0.04
441
4692
18
127
1.43
0.68
11.1
3.3
3.54
2.29
index
0.52
13
78
13
185
0.70
0.59
1.9
1.8
14.80
16.34
u/ml
—
6
62
57
665
0.84
0.57
1.2
1.3
3.20
6.97
u/ml
0.84
13
274
6
36
1.67
0.57
1.3
1.2
56.50
47.38
u/l
—
6
30
101
1126
0.88
0.56
1.7
2.1
1.54
1.52
%
0.05
93
1014
428
4133
1.10
0.56
3.9
3.4
56.88
47.76
u/l
1.25
412
3976
31
249
1.26
0.55
2.2
2.4
43.08
39.59
u/l
0.30
26
223
9
60
1.51
0.54
1.2
1.4
—
—
—
0
0
19
143
1.34
0.53
1.2
1.1
—
—
—
0
0
9
63
1.43
0.52
1.2
1.1
241.22
260.26
mg/l
—
9
57
19
145
1.32
0.49
1.2
1.1
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
7
45
1.56
0.49
1.7
1.7
—
2007631.13
—
0
8
7
46
1.53
0.48
1.0
1.2
272.86
286.78
mg/l
—
7
36
7
48
1.46
0.47
1.1
1.1
—
—
—
0
0
67
751
0.88
0.43
1.3
1.3
12.58
22.75
iu/ml
2.91
17
213
17
131
1.31
0.42
1.2
1.3
—
—
—
0
0
5
33
1.52
0.41
1.2
1.3
0.56
0.52
e9/l
—
5
33
104
1132
0.90
0.41
1.3
1.3
4.21
1.75
u/ml
0.44
27
359
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
5
35
1.43
0.39
1.0
1.4
5.72
6.99
u/l
—
5
29
0
19
0.00
0.39
0.0
1.0
—
5.10
—
0
19
30
252
1.20
0.38
3.2
3.0
—
—
—
0
0
29
341
0.84
0.35
1.2
1.1
0.92
0.72
ratio
—
5
31
22
181
1.22
0.35
2.2
1.9
5.30
5.37
iu/ml
—
7
45
31
357
0.86
0.31
1.2
1.1
1.31
1.41
g/l
2.09
31
357
33
288
1.15
0.29
3.3
3.0
—
—
—
0
0
13
103
1.27
0.28
1.1
1.1
3.64
16.36
au/ml
—
5
45
55
499
1.11
0.28
8.0
6.3
—
—
—
0
0
32
364
0.87
0.28
1.2
1.1
0.98
0.93
g/l
0.45
32
364
226
2175
1.06
0.28
2.0
1.9
1.62
1.51
mmol/l
0.92
189
1900
396
3878
1.05
0.25
3.0
3.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
45
412
1.10
0.21
1.6
1.8
0.45
0.33
mg/l
0.45
24
229
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
173.71
—
0
7
22
193
1.14
0.20
1.3
1.3
195.00
175.94
miu/ml
—
9
76
12
99
1.22
0.19
1.1
1.2
11.49
15.34
u/l
0.56
12
88
86
907
0.94
0.18
1.8
2.0
4.12
3.97
ratio
0.37
60
696
27
242
1.12
0.18
1.0
1.1
—
—
—
0
0
204
1980
1.04
0.18
2.8
2.5
71.85
71.11
nmol/l
0.13
186
1838
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
72
683
1.06
0.15
1.5
1.6
3.93
3.62
mmol/l
0.88
43
459
477
4815
0.97
0.13
4.6
4.4
6.00
5.98
mmol/l
0.11
434
4496
159
1547
1.04
0.13
4.3
4.6
8.07
10.20
mg/mmol
0.32
106
1053
27
250
1.08
0.11
1.3
1.2
—
—
—
0
0
93
902
1.04
0.09
1.8
1.8
429.20
32041758.42
pmol/l
0.97
74
774
5
48
1.04
0.09
1.0
1.0
1438.80
1531.13
miu/ml
—
5
48
5
61
0.82
0.08
2.6
2.7
11.60
10.70
mmol/l
—
5
61
6
72
0.83
0.07
1.3
1.5
—
—
—
0
0
8
74
1.08
0.07
1.0
1.0
—
—
—
0
0
114
1162
0.98
0.06
1.6
1.5
—
—
—
0
0
114
1122
1.02
0.04
3.2
3.3
1.02
1.02
kg/l
1.40
73
702
15
140
1.07
0.04
1.7
2.4
62.62
124.94
ug/min
—
10
80
32
308
1.04
0.04
8.8
8.6
24.44
24.44
mmol/l
0.00
32
294
19
180
1.06
0.04
1.1
1.3
—
—
—
0
0
14
132
1.06
0.02
1.1
1.6
—
—
—
0
0
14
133
1.05
0.01
5.0
1.4
0.27
0.23
g/l
0.66
14
126
14
133
1.05
0.01
5.0
1.4
1.31
1.16
g/l
0.95
14
126
184
1834
1.00
0.00
3.6
4.1
9.35
9.25
mmol/l
0.08
152
1620
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
0.00
1.4
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
-0.00
1.2
1.3
86.20
87.45
umol/l
—
5
49
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
2.96
—
0
7
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
5.3
5.4
—
—
—
0
0
6
68
0.88
-0.00
1.7
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_TESTIS – Malignant neoplasm of testis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).